BloodGPT
Category: AI in Healthcare
An AI-powered platform that analyzes and interprets complex blood test reports, delivering actionable insights in under two minutes. BloodGPT was founded in 2024. The company is led by Jonathan Kron. Based in Nicosia, Cyprus. Team size: 11-50. Total funding raised: $1 million. Latest round: Seed. Key investors include Self-funded by founders, Current efforts focus on strategic investment from healthcare entities..
- Founded
- 2024
- Headquarters
- Nicosia, Cyprus
- Team size
- 11-50
- Total funding
- $1 million
Value proposition
Provides rapid, accurate blood analysis in 98 languages, making lab results understandable for all users.
Products and solutions
AI-driven blood analysis platform, Health trend tracking and personalized recommendations
Unique value
Employs a multi-agent AI architecture specifically designed for medical data, enhancing accuracy and minimizing errors compared to generic models.
Target customer
Individual consumers (B2C) and healthcare professionals (B2B).
Industries served
Healthcare, AI, Diagnostics
Technology advantage
Speed (analysis within two minutes), accuracy (custom-built for healthcare), and accessibility (support for multiple languages and interpretation formats).
How they differentiate
Focuses purely on software solutions that interpret standard blood test results, emphasizing user-friendly interfaces and multilingual support.
Main competitors
Sight Diagnostics, LabCorp, Quest Diagnostics, Other AI health diagnostic startups
Key partnerships
Closed partnerships with healthcare providers are in development for better integration.
Major milestones
Platform launch Over 500 consumer subscribers acquired Secured $1 million in seed funding.
Growth metrics
Over 500 active paying subscribers and numerous positive user feedback.
Market positioning
Innovative player in health-tech and medical diagnostics, positioned for B2C and B2B growth and service.
Geographic focus
Global, with services available in 98 different languages.
Patents and IP
Not specified, but the company aims to develop proprietary technology as it grows.
About Jonathan Kron
Jonathan Kron is a healthcare strategist and entrepreneur with 20+ years of experience building and scaling healthcare ventures. Before joining BloodGPT he founded and exited Med24, a London-based clinic (raised £5M, exited 2022), co-founded PCG, a Monaco-based healthcare-at-home startup, and has advised digital health ventures including Klarity and LIPS Healthcare.
More AI in Healthcare companies
Official website: https://bloodgpt.com/